CANbridge Pharmaceuticals Inc. has announced that the Taiwan Food and Drug Administration (TFDA) has accepted the New Dr...
Biocytogen Pharmaceuticals (Beijing) Co., has announced the opening of the Biocytogen Europe Innovation Centre (BEIC) in...
InnoCare Pharma has received Investigational New Drug (IND) approval of clinical trial from the NMPA (National Medical P...
Innovent Biologics and Eli Lilly and Company have announced that the companies will now expand the strategic partnership...
Amid the severity of the fifth wave of the COVID-19 pandemic, a startup nurtured by The Hong Kong Polytechnic University...
Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, has entered i...
After two years of battling the COVID-19 pandemic, the World Health Organization (WHO) has suggested that while most peo...
CARsgen Therapeutics, a company focused on innovative CAR T cell therapies for the treatment of hematologic malignancies...
VivaVision Biotech, Inc. (VivaVision), an ophthalmic pharmaceutical developer focusing on discovery and development of i...
Broncus has announced that the company's thermal vapour treatment system InterVapor has been granted approval by the Nat...
Transcenta Holding Limited, a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, ...
OBiO Technology has completed its initial public offering ("IPO") process and started trading on the Shanghai Stock...
Denmark's Bavarian Nordic has entered into an exclusive license and supply agreement with Nuance Pharma, a Shanghai-base...
China-based Zai Lab Limited has announced the appointment of Josh Smiley as its Chief Operating Officer (COO). Smiley br...
Triastek, Inc. and Siemens Ltd., China have signed a strategic collaboration agreement to provide digital tech...
HitGen has entered into a research collaboration agreement with Howard Hughes Medical Institute ("HHMI") and Duke Univer...
Harvest Integrated Research Organization (HiRO) has announced the completion of its Series A financing in the tens of mi...
Lynk Pharmaceuticals and Simcere announced a strategic partnership to develop and commercialize a highly selective JAK1 ...
